Shares of Cano Health, Inc. (NYSE:CANO) reached a new 52-week low on Thursday . The company traded as low as $6.96 and last traded at $6.97, with a volume of 14187 shares traded. The stock had previously closed at $7.30.
A number of research firms recently weighed in on CANO. Zacks Investment Research lowered shares of Cano Health from a “buy” rating to a “hold” rating in a research note on Tuesday. Wolfe Research began coverage on Cano Health in a report on Friday, October 1st. They issued an “outperform” rating and a $19.00 price target for the company. Piper Sandler upped their price target on Cano Health from $11.00 to $13.00 and gave the company a “neutral” rating in a report on Wednesday, November 10th. Cowen lowered their price target on Cano Health from $18.00 to $15.00 and set an “outperform” rating for the company in a report on Tuesday, December 7th. Finally, Jefferies Financial Group began coverage on Cano Health in a report on Wednesday, October 20th. They issued a “buy” rating and a $17.00 price target for the company. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $16.00.
The business has a 50-day moving average price of $9.40 and a two-hundred day moving average price of $11.08. The company has a debt-to-equity ratio of 1.07, a current ratio of 3.33 and a quick ratio of 3.32.
In other Cano Health news, Director Solomon D. Trujillo purchased 97,000 shares of the firm’s stock in a transaction on Thursday, November 18th. The shares were purchased at an average cost of $10.55 per share, with a total value of $1,023,350.00. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Marlow Hernandez purchased 15,000 shares of the firm’s stock in a transaction on Monday, December 6th. The stock was acquired at an average cost of $8.00 per share, for a total transaction of $120,000.00. The disclosure for this purchase can be found here. In the last ninety days, insiders have purchased 132,500 shares of company stock worth $1,329,925.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in CANO. FMR LLC acquired a new position in shares of Cano Health in the 2nd quarter valued at about $423,303,000. Third Point LLC acquired a new position in shares of Cano Health in the 2nd quarter valued at about $134,119,000. ArrowMark Colorado Holdings LLC acquired a new position in shares of Cano Health in the 2nd quarter valued at about $133,628,000. Maverick Capital Ltd. acquired a new position in shares of Cano Health in the 2nd quarter valued at about $96,039,000. Finally, Wellington Management Group LLP acquired a new position in shares of Cano Health in the 3rd quarter valued at about $65,147,000. 38.47% of the stock is currently owned by institutional investors and hedge funds.
About Cano Health (NYSE:CANO)
Cano Health, LLC owns and operates health care centers and pharmacies. It provides medical, dental, urgent care, an in-house laboratory, and specialty services. The company offers patient-centric programs, such as home visits, telehealth, transition of care, and high risk and complex care management.
Featured Story: What are the risks of holding treasury bonds?
Receive News & Ratings for Cano Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cano Health and related companies with MarketBeat.com's FREE daily email newsletter.